Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma.
Détails
Télécharger: 39313500.pdf (3517.69 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_3003F0E051CF
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma.
Périodique
Blood cancer journal
ISSN
2044-5385 (Electronic)
ISSN-L
2044-5385
Statut éditorial
Publié
Date de publication
23/09/2024
Peer-reviewed
Oui
Volume
14
Numéro
1
Pages
166
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Publication Status: epublish
Résumé
Mantle cell lymphoma (MCL) is genetically characterized by the IG::CCND1 translocation mediated by an aberrant V(D)J rearrangement. CCND1 translocations and overexpression have been identified in occasional aggressive B-cell lymphomas with unusual features for MCL. The mechanism generating CCND1 rearrangements in these tumors and their genomic profile are not known. We have reconstructed the IG::CCND1 translocations and the genomic profile of 13 SOX11-negative aggressive B-cell lymphomas using whole genome/exome and target sequencing. The mechanism behind the translocation was an aberrant V(D)J rearrangement in three tumors and by an anomalous IGH class-switch recombination (CSR) or somatic hypermutation (SHM) mechanism in ten. The tumors with a V(D)J-mediated translocation were two blastoid MCL and one high-grade B-cell lymphoma. None of them had a mutational profile suggestive of DLBCL. The ten tumors with CSR/SHM-mediated IGH::CCND1 were mainly large B-cell lymphomas, with mutated genes commonly seen in DLBCL and BCL6 rearrangements in 6. Two cases, which transformed from marginal zone lymphomas, carried mutations in KLF2, TNFAIP3 and KMT2D. These findings expand the spectrum of tumors carrying CCND1 rearrangement that may occur as a secondary event in DLBCL mediated by aberrant CSR/SHM and associated with a mutational profile different from that of MCL.
Mots-clé
Humans, Lymphoma, Mantle-Cell/genetics, Lymphoma, Mantle-Cell/pathology, Cyclin D1/genetics, Lymphoma, Large B-Cell, Diffuse/genetics, Male, Female, Translocation, Genetic, Middle Aged, Aged, Chromosome Breakpoints, Genes, Immunoglobulin, Gene Rearrangement, V(D)J Recombination/genetics
Pubmed
Web of science
Open Access
Oui
Création de la notice
25/09/2024 8:17
Dernière modification de la notice
31/10/2024 7:13